CBE ID
0630
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description
The percentage of patients aged 18 to75 years with a diagnosis of diabetes whose most recent HbA1c value is between 8 and 10 percent and who are taking metformin.
Measure Specs
General Information
1.7 Measure Type
1.3 Electronic Clinical Quality Measure (eCQM)
No
1.8 Level of Analysis
1.9 Care Setting
1.20 Types of Data Sources
Numerator
1.14 Numerator
Patients with a current fill for metformin
Denominator
1.15 Denominator
Patients aged 18 to75 years with a diagnosis of diabetes whose most recent HbA1c value is between 8 and 10 percent
Exclusions
Exclusions
Specific exclusions:
Patients with type 1 diabetes, gestational diabetes, orcontraindications to metformin use such as allergy, chronic kidney disease, liver disease, acidosis, hypoxemia, heart failure
General exclusions:
• Evidence of metastatic disease or active treatment of malignancy (chemotherapy or radiation therapy) in the last 6 months;
• Patients who have been in a skilled nursing facility in the last 3 months
Measure Record
Most Recent Endorsement Activity
Measure Retired and Endorsement Removed National Voluntary Consensus Standards For Clinically Enriched Administrative Data
Initial Endorsement
Last Updated
Removal Date
Point of Contact
Steward Organization
ActiveHealth Management
Steward POC email
Importance
Care Gaps
Feasibility
Scientific Acceptability
Risk Adjustment
Risk Adjustment
Use & Usability
Use
6.1.2 Current or Planned Use(s)
6.1.3 Current or Planned Use(s)
Public Comments